On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Office of the Director

InstitutionResearch output, impact & collaborations

Office of the Director is a institution indexed in ScholarIQ from OpenAlex.

What is known about Office of the Director?

ScholarIQrecord summary

Office of the Director is a research organisation in Bethesda, US. OpenAlex records 5,986 works and 926,833 citations for it. 1,077 researchers list it as their most recent affiliation.

How many works does Office of the Director have?

ScholarIQindexed works

Office of the Director has 5,986 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Office of the Director have?

ScholarIQcitation count

Office of the Director has 926,833 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Office of the Director?

ScholarIQresearcher count

Office of the Director has 1,077 researchers in the ScholarIQ index.

What is the average h-index at Office of the Director?

ScholarIQavg h-index

Office of the Director has an average h-index of 86.4 in OpenAlex.

What is the ROR of Office of the Director?

ScholarIQror

The ROR for Office of the Director is on the source record.

What is the OpenAlex record for Office of the Director?

ScholarIQopenalex

The OpenAlex for Office of the Director is on the source record.

Who are the most-cited researchers behind Office of the Director?

ScholarIQtop researchers by citations
1
Yves Pommier · Cancer therapeutics and mechanisms
2,071 works81,252 citations
2
Christine Miaskowski · Cancer survivorship and care
845 works46,571 citations
3
Ellen Leibenluft · Bipolar Disorder and Treatment
567 works39,903 citations
4
William D. Figg · Prostate Cancer Treatment and Research
1,213 works38,477 citations
5
Charles R. Gerfen · Neuroscience and Neuropharmacology Research
190 works33,558 citations

What are the most-cited papers on Office of the Director?

ScholarIQmost cited works
Topoisomerase I inhibitors: camptothecins and beyond
Yves Pommier
Nature reviews. Cancer. 20062,258 CitationsOPEN ACCESS
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das, Amèlie Renaud, Yiping Zhang, James H. Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier
Cancer Research. 20122,201 CitationsOPEN ACCESS
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier, Elisabetta Leo, Hongliang Zhang, Christophe Marchand
Chemistry & Biology. 20101,842 CitationsOPEN ACCESS
γH2AX and cancer
William M. Bonner, Christophe E. Redon, Jennifer S. Dickey, Asako Nakamura, Olga A. Sedelnikova, Stéphanie Solier, Yves Pommier
Nature reviews. Cancer. 20081,611 CitationsOPEN ACCESS
A gene expression database for the molecular pharmacology of cancer
Uwe Scherf, Douglas T. Ross, Mark Waltham, Lawrence H. Smith, Jae K. Lee, Lorraine Tanabe, Kurt W. Kohn, William C. Reinhold, Timothy G. Myers, Darren T. Andrews, Dominic A. Scudiero, Michael B. Eisen, Edward A. Sausville, Yves Pommier, David Botstein, Patrick O. Brown, John N. Weinstein
Nature Genetics. 20001,465 Citations

How much of the research on Office of the Director is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
8%
Bronze
25%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial